PMID: 8942395Nov 1, 1996Paper

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

Clinical Science
G F WattsJ A Millar

Abstract

1. We measured endothelium-dependent and independent dilatation of forearm resistance arteries in 29 men with diet-treated non-insulin-dependent diabetes mellitus and 18 age- and sex-matched control subjects. None of the diabetic patients had hypercholesterolaemia, overt hypertension or microproteinuria. 2. We examined endogenous and exogenous nitric oxide-mediated vasodilatation by measuring forearm blood flow with venous occlusive plethysmography after administration of acetylcholine (7.5 and 15 micrograms/min) and sodium nitroprusside (3 and 10 micrograms/min), respectively, into the brachial artery. NG-monomethyl-L-arginine was also infused to study the inhibition of basal and stimulated release of nitric oxide. 3. The vasodilatory response to acetylcholine, expressed as area under curve, was significantly decreased in the diabetic patients compared with the control subjects (P = 0.019). NG-monomethyl-L-arginine significantly reduced basal (P < 0.001) and acetylcholine-stimulated blood flow (P < 0.02) in both groups. The vasodilatory response (also expressed as area under curve) to sodium nitroprusside was significantly less (P = 0.044) in the diabetic patients than in the control subjects. 4. In the diabetic patients, impa...Continue Reading

Citations

Nov 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·D R MeekingK M Shaw
Apr 25, 2000·Clinical and Experimental Pharmacology & Physiology·B A Kingwell
Jun 1, 2000·Australian and New Zealand Journal of Medicine·L J BeilinP L Thompson
Dec 18, 2001·Journal of Cardiovascular Pharmacology·Jane Elizabeth RamsayNaveed Sattar
Oct 17, 2001·Circulation·B J O'Connell, J Genest
Mar 21, 2002·European Journal of Clinical Investigation·E K Naderali, G Williams
May 25, 2002·European Journal of Clinical Investigation·K C B TanK S L Lam
Jun 13, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·N IhlemannP C Eskildsen
Nov 28, 2002·Diabetes Care·José Manuel Fernández-RealWifredo Ricart
Mar 26, 2003·QJM : Monthly Journal of the Association of Physicians·A-Y ChongG Y H Lip
Sep 18, 2004·The Journal of Physiology·Daniel J GreenRoger Taylor
Jul 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Danielle J PadillaDavid C Poole
Aug 23, 2006·Clinical and Experimental Pharmacology & Physiology·Paul Nestel
Sep 20, 2006·International Journal of Clinical Practice·A Ferro
Jul 27, 2007·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Sandra J HamiltonGerald F Watts
Feb 4, 2009·Antioxidants & Redox Signaling·Munir Boodhwani, Frank W Sellke
Feb 11, 2016·International Journal of Environmental Research and Public Health·Michaela Kozakova, Carlo Palombo
Jun 24, 2020·Clinical and Experimental Hypertension : CHE·Romário Divino Vilarinho GalvãoSebastião Rodrigues Ferreira-Filho
Mar 21, 2002·Clinical and Experimental Pharmacology & Physiology·I B PuddeyL J Beilin
Jul 17, 2001·European Journal of Clinical Investigation·G A Rongen, C J Tack
Aug 24, 1999·British Journal of Pharmacology·N Hutri-KähönenI Pörsti
Jun 27, 2000·Australian and New Zealand Journal of Medicine·D Playford, G F Watts
Jun 5, 2003·Journal of Hypertension·Michael L Tuck
Aug 25, 2006·The International Journal of Lower Extremity Wounds·Jordan C SchrammAristidis Veves
Mar 20, 2003·Current Diabetes Reports·Sari Mäkimattila, Hannele Yki-Järvinen
Sep 24, 2004·Clinical Physiology and Functional Imaging·Seong S ChuahPhilip S Lewis
Jul 30, 2010·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Sandra J HamiltonGerald F Watts
May 10, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Styliani GoulopoulouR Clinton Webb
Feb 9, 2018·Clinical and Experimental Hypertension : CHE·Badiaa LyoussiMaurice Wibo
Apr 15, 1999·European Journal of Clinical Investigation·J C ter MaatenR O Gans
Feb 13, 2001·Endocrine Reviews·J Calles-Escandon, M Cipolla
Apr 29, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·A GazisJ R Cockcroft
Feb 28, 2004·Diabetes Care·José-Manuel Fernández-RealWifredo Ricart
Mar 20, 2003·Current Diabetes Reports·Ajay Chaudhuri
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·S VehkavaaraH Yki-Järvinen
Nov 1, 2005·Expert Opinion on Investigational Drugs·Dirk C Felmeden, Gregory Y H Lip
Apr 24, 2008·European Journal of Heart Failure·Joanna M YoungRussell S Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.